Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
1999 1
2000 1
2001 1
2002 1
2004 5
2005 2
2007 2
2008 2
2009 1
2010 5
2011 7
2012 5
2013 3
2014 7
2015 7
2016 12
2017 8
2018 11
2019 12
2020 11
2021 9
2022 9
2023 5
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 36191969

108 results

Results by year

Filters applied: . Clear all
Page 1
Concurrent Chemoradiotherapy With Docetaxel, Cisplatin, and 5-Fluorouracil (DCF-RT) vs. Cisplatin and 5-Fluorouracil (CF-RT) for Patients With Unresectable Locally Advanced Esophageal Cancer in a Real-world Clinical Setting.
Sakai M, Sohda M, Saito H, Nakazawa N, Ubukata Y, Kuriyama K, Hara K, Sano A, Ogawa H, Yokobori T, Murata K, Noda SE, Ohno T, Shirabe K, Saeki H. Sakai M, et al. Anticancer Res. 2021 Apr;41(4):2141-2145. doi: 10.21873/anticanres.14986. Anticancer Res. 2021. PMID: 33813425
A prospective, multicenter phase I/II study of induction chemotherapy with docetaxel, cisplatin and fluorouracil (DCF) followed by chemoradiotherapy in patients with unresectable locally advanced esophageal carcinoma.
Satake H, Tahara M, Mochizuki S, Kato K, Hara H, Yokota T, Kiyota N, Kii T, Chin K, Zenda S, Kojima T, Bando H, Yamazaki T, Iwasa S, Honma Y, Hamauchi S, Tsushima T, Ohtsu A. Satake H, et al. Cancer Chemother Pharmacol. 2016 Jul;78(1):91-9. doi: 10.1007/s00280-016-3062-2. Epub 2016 May 18. Cancer Chemother Pharmacol. 2016. PMID: 27193097 Free PMC article. Clinical Trial.
Docetaxel, cisplatin, and 5-fluorouracil combination chemoradiotherapy for patients with cervical esophageal cancer: a single-center retrospective study.
Sakai M, Sohda M, Saito H, Kuriyama K, Yoshida T, Kumakura Y, Hara K, Yokobori T, Miyazaki T, Murata K, Noda SE, Nakano T, Kuwano H, Shirabe K. Sakai M, et al. Cancer Chemother Pharmacol. 2019 Jun;83(6):1121-1126. doi: 10.1007/s00280-019-03835-0. Epub 2019 Apr 9. Cancer Chemother Pharmacol. 2019. PMID: 30972455
A management of neutropenia using granulocyte colony stimulating factor support for chemotherapy consisted of docetaxel, cisplatin and 5-fluorouracil in patients with oesophageal squamous cell carcinoma.
Katada C, Sugawara M, Hara H, Fujii H, Nakajima TE, Ando T, Kojima T, Watanabe A, Sakamoto Y, Ishikawa H, Hosokawa A, Hamamoto Y, Muto M, Tahara M, Koizumi W. Katada C, et al. Jpn J Clin Oncol. 2021 Feb 8;51(2):199-204. doi: 10.1093/jjco/hyaa190. Jpn J Clin Oncol. 2021. PMID: 33147611
Definitive chemoradiation therapy with docetaxel, cisplatin, and 5-fluorouracil (DCF-R) in advanced esophageal cancer: a phase 2 trial (KDOG 0501-P2).
Higuchi K, Komori S, Tanabe S, Katada C, Azuma M, Ishiyama H, Sasaki T, Ishido K, Katada N, Hayakawa K, Koizumi W; Kitasato Digestive Disease and Oncology Group. Higuchi K, et al. Int J Radiat Oncol Biol Phys. 2014 Jul 15;89(4):872-9. doi: 10.1016/j.ijrobp.2014.03.030. Epub 2014 May 24. Int J Radiat Oncol Biol Phys. 2014. PMID: 24867539 Clinical Trial.
108 results